(Q45382904)

English

Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma.

scientific article published on 7 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

H Nyman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

E Jantunen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

E Juvonen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

E Elonen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J Böhm

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

V-M Kosma

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

G Enblad

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M-L Karjalainen-Lindsberg

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

0 references

publication date

7 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

93-98

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

https://scigraph.springernature.com/pub.10.1038/bmt.2008.92

0 references

Molecular pathogenesis of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

NF-kappaB at the crossroads of life and death

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2008.92

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391989%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45382904&oldid=1455493620"